Literature DB >> 27372436

Impact of sleep quality on the quality of life of patients with Parkinson's disease: a questionnaire based study.

Shweta Pandey1, Bhupender Kumar Bajaj2, Ankur Wadhwa1, Kuljeet Singh Anand1.   

Abstract

OBJECTIVE: Poor sleep quality contributes to the inferior quality of life of patients with Parkinson's disease (PD) despite appropriate treatment of motor symptoms. The literature about the impact of sleep quality on quality of life of patients with PD is as yet sparse.
MATERIAL AND METHODS: One hundred patients of PD diagnosed as per UK Brain Bank criteria were assessed for severity and stage of PD using UPDRS and modified Hoehn &Yahr scales. The quality of sleep was assessed by Pittsburgh Sleep Quality Index and excessive daytime somnolence (EDS) was evaluated using Epworth Sleepiness Scale. Parkinson's Disease Questionnaire -39 (PDQ-39) was used to determine quality of life of the patients. Comorbid depression and anxiety were assessed using Inventory of Depressive Symptoms-Self Rated and Hamilton Anxiety Rating Scale. Pearson's correlation and multiple linear regressions were used to analyze relation of sleep quality with quality of life of patients.
RESULTS: Fifty patients had poor sleep quality. EDS was present in only 9 patients. Co-morbid depression and anxiety were present in 52 and 34 patients respectively. While the motor severity assessed by UPDRS-III was observed to adversely affect quality of life, it did not negatively impact quality of sleep. Higher score on UPDRS-total and UPDRS IV suggesting advanced disease correlated with poor sleep quality. Depression and anxiety were significantly more frequent in patients with poor sleep quality (p<0.01). Patients with poor sleep quality had worse quality of life (r=0.338, p<0.05). Depression and anxiety were also observed to have significant negative impact on quality of life of PD patients (p<0.01). Poor sleep quality was not found to be an independent predictor of quality of life using multiple linear regression analysis.
CONCLUSION: Poor sleep quality along with comorbid depression, anxiety and advanced stage of disease is associated with poor quality of life.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Excessive daytime somnolence; Non-motor symptoms; PDQ39; Parkinson's disease; Quality of life; Sleep

Mesh:

Year:  2016        PMID: 27372436     DOI: 10.1016/j.clineuro.2016.06.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  13 in total

Review 1.  Disturbances of Sleep and Alertness in Parkinson's Disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

2.  Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease.

Authors:  Qu Yi; Chen Yu-Peng; Li Jiang-Ting; Li Jing-Yi; Qin Qi-Xiong; Wang Dan-Lei; Zhao Jing-Wei; Mao Zhi-Juan; Xiong Yong-Jie; Min Zhe; Xue Zheng
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

3.  Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.

Authors:  Fabian Büchele; Marc Hackius; Sebastian R Schreglmann; Wolfgang Omlor; Esther Werth; Angelina Maric; Lukas L Imbach; Stefan Hägele-Link; Daniel Waldvogel; Christian R Baumann
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

4.  SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE.

Authors:  Priti Gros; Aleksandar Videnovic
Journal:  Curr Sleep Med Rep       Date:  2017-07-06

5.  Sexual dimorphism in Parkinson's disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females.

Authors:  Farzaneh Farhadi; Kia Vosoughi; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk; Seyed-Mohammad Fereshtehnejad
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-01       Impact factor: 2.570

6.  Sleep disturbances in Parkinson's disease are associated with central parkinsonian pain.

Authors:  N Vila-Chã; S Cavaco; A Mendes; A Gonçalves; I Moreira; J Fernandes; J Damásio; L F Azevedo; J Castro-Lopes
Journal:  J Pain Res       Date:  2019-07-12       Impact factor: 3.133

7.  Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study.

Authors:  Haiyan Zhou; Shuhua Li; Hongmei Yu; Shenggang Sun; Xinhua Wan; Xiaodong Zhu; Chun-Feng Liu; Ling Chen; Wei Xiang; Yaqing Sun; Haibo Chen; Shengdi Chen
Journal:  Parkinsons Dis       Date:  2021-03-03

8.  Sleep disturbances in Taiwanese patients with Parkinson's disease.

Authors:  Yi-Ying Lin; Rou-Shayn Chen; Chin-Song Lu; Ying-Zu Huang; Yi-Hsin Weng; Tu-Hsueh Yeh; Wey-Yil Lin; June Hung
Journal:  Brain Behav       Date:  2017-09-21       Impact factor: 2.708

9.  Influence of Mild Cognitive Impairment, Depression, and Anxiety on the Quality of Life of Patients with Parkinson Disease.

Authors:  Daniel Wiesli; Antonia Meyer; Peter Fuhr; Ute Gschwandtner
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-09-28

Review 10.  Chronic Pain Treatment Strategies in Parkinson's Disease.

Authors:  Amber Edinoff; Niro Sathivadivel; Timothy McBride; Allyson Parker; Chikezie Okeagu; Alan D Kaye; Adam M Kaye; Jessica S Kaye; Rachel J Kaye; Meeta M Sheth; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.